VITALITY BIOPHARMA INC (OTCMKTS:VBIO) Sellers Decreased Their Shorts By 20.55%

June 27, 2018 - By Mark Williams

VITALITY BIOPHARMA INC (OTCMKTS:VBIO) showed a decrease of 20.55% in short interest. FINRA published in June VBIO’s total 183,600 short interest. The 231,100 previous shares are down with 20.55%. Former VBIO’s position will need 2 days to restore. It has 106,500 average volume. VITALITY BIOPHARMA INC’s short interest float is 0.99%.

Ticker’s shares touched $1.55 during the last trading session after 5.49% change.Currently Vitality Biopharma, Inc. is after 0.00% change in last June 27, 2017. VBIO has also 90,731 shares volume. VBIO underperformed the S&P500 by 12.57%.

Vitality Biopharma, Inc. focuses on the development of cannabinoid pharmaceuticals for the treatment of neurological and inflammatory disorders in the United States.The firm is valued at $34.87 million. The Company’s products in pipeline include VITA-100, an oral cannabinoid formulation that is used for the acute treatment of inflammatory bowel disease and narcotic bowel syndrome; and VITA-210, a cannabinoid formulation, which is in preclinical studies for use in the chronic treatment of neuropathic pain, irritable bowel syndrome, muscle spasticity in multiple sclerosis, and opioid-induced bowel dysfunction.Currently it has negative earnings. The firm was formerly known as Stevia First Corp. and changed its name to Vitality Biopharma, Inc. in July 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.